Typography

Share This

Two industry innovators are joining forces to take the lead in real-world studies. Clinerion and Cisiv have formed a groundbreaking partnership to offer a revolutionary approach to observational research by enabling automated data transfer from electronic hospital records (EHRs) to electronic data capture (EDC).

Clinerion’s Patient Recruitment System applies intelligent, patented informatics methodologies to extract and interpret information from EHRs, aggregating healthcare information across institutions and geographies to create one single, comprehensive real-time view. Cisiv’s Baseline Plus provides a flexible, cost effective, quick to implement and easy to use EDC system for non-expert users.

“Working with Clinerion forms an important part of Cisiv's strategy to provide a platform that combines structured prospective data capture with near real-time extraction from a broad range of data sources. Clinerion's innovative technology is a great fit with Cisiv's unique approach to real world data, which is why we are very excited about this new partnership,” says Dominic Farmer, CEO of Cisiv.

“Offering new ways to simplify data collection for studies aligns perfectly with Clinerion’s overall goal of creating new efficiencies in the entire clinical trial process, saving time and costs in the development of new drugs, and speeding up the delivery of new medicines to the patients who need them,” says Ulf Claesson, CEO, Clinerion

Real-world research is about making sense of the seeming randomness and diversity of real life. Clinerion and Cisiv share a vision of using technology to make real-world research leaner, easier to implement and ultimately more cost-efficient.

About CisivCISIV has worked closely with leading pharmaceutical companies for over 10 years, developing collaborative web platforms for use in post-approval activities. Baseline Plus was developed to meet the need to capture essential real world data in an international setting. Its aim is to make data entry easy and intuitive yet maintain high quality, essential in large, long-term, non-interventional studies with low levels of monitoring.Cisiv website: www.cisiv.com